论文部分内容阅读
目的:观察补脾益肠丸联合西药治疗结合专项护理干预腹泻型肠易激综合征患者的疗效及安全性。方法:选取100例腹泻型肠易激综合征患者作为研究对象,并随机分入观察组和对照组各50例。对照组服用匹维溴胺片联合蒙脱石散进行治疗,采用常规护理;观察组在对照组治疗的基础上加用补脾益肠丸治疗联合肠易激综合征专项护理进行干预。观察比较2组患者症状改善情况、复发情况和不良反应情况以评价治疗效果。结果:治疗后,观察组患者症状改善情况优于对照组,差异有统计学意义(P<0.05)。随访6月,观察组复发率低于对照组,差异有统计学意义(P<0.01)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:应用补脾益肠丸联合西药治疗结合专项护理干预腹泻型肠易激综合征患者有良好疗效,在症状改善情况、复发情况和不良反应情况方面均优于西药治疗结合常规护理。
Objective: To observe the efficacy and safety of Bupi Yichang Pill combined with western medicine and special nursing intervention in patients with diarrhea-predominant irritable bowel syndrome. Methods: 100 cases of diarrhea-predominant irritable bowel syndrome were selected as study subjects and randomly divided into observation group (50 cases) and control group (50 cases). The patients in the control group were treated with pivalivirum tablets combined with montmorillonite powder. The patients in the observation group were given conventional nursing. The observation group was treated with Bupi Yichang Pills in combination with special treatment of irritable bowel syndrome. Observed in 2 groups of patients to improve the symptoms, relapse and adverse reactions to evaluate the treatment effect. Results: After treatment, symptom improvement in observation group was better than that in control group, the difference was statistically significant (P <0.05). Follow-up in June, the observation group recurrence rate was lower than the control group, the difference was statistically significant (P <0.01). The incidence of adverse reactions in the two groups, the difference was not statistically significant (P> 0.05). Conclusion: Bupi Yichang Pills combined with Western medicine combined with special nursing intervention in patients with diarrhea-predominant irritable bowel syndrome has a good curative effect, and is superior to Western medicine in the treatment of symptoms and symptoms, recurrence and adverse reactions.